New patients10% off your first order.

Hormone optimization

Hormone care for midlife, guided by labs and symptoms

Hot flashes, poor sleep, low drive, fading strength and mood changes are often written off as aging. Sometimes hormones are part of the story. Here is how HealifyMD clinicians figure that out and what treatment can involve.

Women's hormone therapy
$349 first month, then $99/month
Men's testosterone therapy
$249 first month, then $149/month
Enclomiphene ODT (compounded)
From $129/month
Labs
Priced separately

What hormone optimization means here

Hormones such as estrogen, progesterone and testosterone influence sleep, mood, sexual function, muscle, bone and metabolism. Their levels change across life, and in midlife those changes can produce symptoms that affect how you function day to day.

At HealifyMD, hormone care means treating a documented deficiency or bothersome menopausal symptoms with the lowest effective approach, then monitoring. It does not mean pushing levels as high as possible or treating a number without symptoms. The goal is how you feel and how safe the treatment is, with labs as a guide.

For women: perimenopause and menopause

Perimenopause can start in your 40s, and the menopause transition often brings hot flashes, night sweats, sleep disruption, mood changes, vaginal dryness and bone loss. Hormone therapy is the most effective treatment for hot flashes and also treats vaginal symptoms and helps prevent bone loss.

Treatment typically combines estrogen with progesterone if you have a uterus, because estrogen alone raises the risk of endometrial cancer. Risks such as blood clots, stroke and breast cancer depend on your age, how long since menopause, your health history, the type of hormone and how it is delivered. For most healthy women, benefits are most favorable when hormone therapy is started before age 60 or within 10 years of menopause.

For men: testosterone deficiency

Testosterone declines gradually in many men, but low testosterone is diagnosed only when consistent symptoms are paired with low levels on at least two early-morning blood tests. Guidelines from the American Urological Association use a total testosterone below 300 ng/dL as a reasonable cut-off.

Testosterone therapy can improve symptoms of a true deficiency. It also suppresses sperm production, can raise red blood cell counts and blood pressure, and requires PSA monitoring. For men who want to preserve fertility, alternatives that stimulate the body's own production, such as enclomiphene, may be discussed. Compounded enclomiphene is not FDA-approved.

How the process works

  • Assessment: a detailed history of symptoms, medications, conditions and family history.
  • Labs: hormone levels and safety markers appropriate to your sex and age, such as blood counts, lipids and PSA for men.
  • Risk discussion: an individual conversation about benefits and risks, including clots, stroke, breast cancer, prostate health and fertility.
  • Plan: the type, dose and delivery route chosen for you.
  • Monitoring: follow-up visits and repeat labs, with adjustments based on symptoms and results.

What has changed in the guidance

Hormone therapy labeling has shifted. In November 2025 the FDA announced it would remove boxed warnings about cardiovascular disease, breast cancer and probable dementia from menopausal hormone therapy labels, while keeping the boxed warning on endometrial cancer for systemic estrogen-alone products. In 2025 the FDA also updated all testosterone labels to add blood pressure warnings and include results of the TRAVERSE trial, which did not find an increase in major cardiovascular events in men with hypogonadism.

These updates change the conversation, not the need for one. Your clinician still weighs your personal risks.

A note on compounded hormones

Several hormone products in our plans are compounded. Compounded hormones are not FDA-approved and are not interchangeable with branded products. The FDA has noted that compounded "bioidentical" hormones have not been shown to be safer or more effective than approved products. FDA-approved bioidentical estradiol and progesterone exist, and you can ask about them.

Who should not start hormone therapy without specialist input

  • Women with a history of breast or endometrial cancer, blood clots, stroke, heart attack or active liver disease, or unexplained vaginal bleeding.
  • Men with prostate or breast cancer, a high hematocrit, untreated severe sleep apnea, uncontrolled heart failure, or a heart attack or stroke in the past six months.
  • Men trying to conceive now or soon, who should not use testosterone.
  • Anyone who is pregnant or breastfeeding.

Common questions

How do I know if my hormones are the problem?

A clinician compares your symptoms with your history and lab results. Many symptoms overlap with thyroid problems, sleep disorders, depression and iron deficiency.

Is hormone therapy safe?

For many healthy women under 60 or within 10 years of menopause, benefits often outweigh risks, but safety depends on your individual history.

Is testosterone therapy safe?

For men with confirmed deficiency it can be appropriate with monitoring of hematocrit, blood pressure and PSA; it is not suitable for everyone.

Do women ever take testosterone?

Sometimes, mainly for low sexual desire after menopause, under specialist guidance; there is no FDA-approved testosterone product for women in the U.S.

Will I need hormones forever?

Not necessarily. Duration is reviewed regularly with your clinician based on your symptoms, risks and goals.

How is this different from a quick online prescription?

Treatment follows labs, an individual risk discussion and scheduled follow-up, and a clinician may decide hormones are not the right answer.

Sources

We cite government agencies, professional societies and peer-reviewed research. See our editorial policy.

  1. HHS Advances Women's Health, Removes Misleading FDA Warnings on Hormone Replacement TherapyU.S. Food and Drug Administration
  2. Hormone TherapyThe Menopause Society
  3. Testosterone Deficiency GuidelineAmerican Urological Association
  4. Testosterone Therapy in Men with Hypogonadism: Clinical Practice GuidelineEndocrine Society
  5. FDA Issues Class-Wide Labeling Changes for Testosterone ProductsU.S. Food and Drug Administration
  6. MenopauseU.S. Food and Drug Administration

Find out what your body needs next

Start with a free eligibility check. A licensed clinician reviews your history and goals, and recommends labs or treatment only if they fit.

  • No membership fee
  • Licensed clinicians
  • 100% online